Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
5.22
Dollar change
-0.08
Percentage change
-1.51
%
IndexRUT P/E- EPS (ttm)-1.89 Insider Own20.94% Shs Outstand66.86M Perf Week-9.69%
Market Cap401.94M Forward P/E- EPS next Y-1.67 Insider Trans37.62% Shs Float60.88M Perf Month19.18%
Income-127.67M PEG- EPS next Q-0.43 Inst Own46.60% Short Float4.40% Perf Quarter188.40%
Sales0.00M P/S- EPS this Y38.63% Inst Trans-5.87% Short Ratio5.08 Perf Half Y14.98%
Book/sh2.42 P/B2.16 EPS next Y1.23% ROA-60.84% Short Interest2.68M Perf Year66.24%
Cash/sh1.58 P/C3.30 EPS next 5Y- ROE-70.69% 52W Range1.66 - 8.09 Perf YTD61.11%
Dividend Est.- P/FCF- EPS past 5Y- ROI-73.47% 52W High-35.49% Beta2.58
Dividend TTM- Quick Ratio6.55 Sales past 5Y0.00% Gross Margin- 52W Low214.46% ATR (14)0.53
Dividend Ex-Date- Current Ratio6.55 EPS Y/Y TTM32.93% Oper. Margin0.00% RSI (14)55.94 Volatility10.97% 11.01%
Employees141 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price19.14
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q46.89% Payout- Rel Volume0.59 Prev Close5.30
Sales Surprise- EPS Surprise17.53% Sales Q/Q- EarningsNov 08 AMC Avg Volume527.50K Price5.22
SMA205.02% SMA5037.26% SMA20028.43% Trades Volume313,674 Change-1.51%
Date Action Analyst Rating Change Price Target Change
Nov-30-23Initiated Leerink Partners Outperform $7
Jun-15-22Initiated H.C. Wainwright Buy $25
Feb-09-24 09:55AM
Feb-08-24 08:00AM
Jan-26-24 12:00PM
Jan-03-24 08:30AM
Nov-21-23 04:30PM
04:05PM Loading…
Nov-08-23 04:05PM
Oct-26-23 08:30AM
Oct-09-23 08:30AM
Oct-05-23 08:30AM
Oct-02-23 05:30PM
Sep-21-23 04:05PM
Aug-31-23 04:05PM
Aug-09-23 04:05PM
Aug-02-23 04:05PM
May-30-23 09:06AM
09:55AM Loading…
May-15-23 09:55AM
May-11-23 08:50AM
May-10-23 04:19PM
May-03-23 08:00AM
07:09AM
May-02-23 07:50AM
Apr-25-23 06:35AM
Apr-23-23 04:02PM
Apr-21-23 04:05PM
Apr-20-23 02:46PM
Apr-19-23 11:36AM
Mar-08-23 04:01PM
Feb-07-23 05:17PM
Jan-26-23 12:00PM
Jan-09-23 07:00AM
06:12AM Loading…
Dec-21-22 06:12AM
Dec-07-22 04:30PM
Dec-02-22 06:36PM
Nov-28-22 08:30AM
Nov-24-22 05:54AM
Nov-23-22 09:00AM
Nov-21-22 05:45PM
Nov-17-22 12:39AM
Nov-16-22 04:01PM
Nov-10-22 04:05PM
Nov-04-22 08:00AM
Oct-14-22 06:12AM
Oct-04-22 08:30AM
Sep-29-22 08:00AM
07:45AM
Sep-26-22 09:21AM
Sep-15-22 09:39AM
Sep-06-22 04:05PM
08:00AM
Aug-16-22 09:55AM
Aug-10-22 04:01PM
Jul-06-22 02:00PM
Jun-16-22 08:00AM
May-20-22 08:30AM
May-11-22 04:09PM
May-07-22 09:38AM
May-03-22 08:00AM
Apr-28-22 08:00AM
Mar-24-22 08:30AM
Mar-23-22 04:05PM
Feb-08-22 12:01PM
Feb-04-22 01:03PM
Jan-31-22 08:00AM
Jan-10-22 08:00AM
Dec-23-21 12:38PM
Dec-22-21 04:05PM
Dec-17-21 10:06AM
Nov-22-21 08:00AM
Nov-19-21 08:00AM
Nov-10-21 04:05PM
Nov-05-21 08:36PM
03:30AM
Nov-03-21 03:41PM
Oct-12-21 06:05PM
Oct-08-21 12:42PM
Oct-04-21 10:54AM
Sep-30-21 06:02PM
Sep-08-21 04:00PM
Aug-31-21 08:00AM
Aug-03-21 04:05PM
Jul-30-21 05:28PM
Jul-29-21 11:46PM
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in August 2016 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoey TimothyChief Scientific OfficerFeb 20Sale5.346,56935,046236,146Feb 21 06:05 PM
Tingley WhittemoreChief Medical OfficerFeb 16Sale5.866,50038,09073,534Feb 16 08:35 PM
Ali FarazChief Executive OfficerFeb 16Sale5.866,35837,258113,079Feb 16 08:30 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerFeb 16Sale5.865,20130,47860,755Feb 16 08:32 PM
Hoey TimothyChief Scientific OfficerFeb 16Sale5.864,68127,431242,715Feb 16 08:37 PM
COLUMN GROUP III GP, LP10% OwnerFeb 12Buy4.502,222,2229,999,99913,599,275Feb 14 04:15 PM
GOEDDEL DAVID VDirectorFeb 12Buy4.502,222,2229,999,99913,599,275Feb 14 04:12 PM
Hoey TimothyChief Scientific OfficerAug 29Sale4.267,24330,855247,396Aug 29 06:59 PM
Ali FarazChief Executive OfficerAug 16Sale3.815,56321,195119,437Aug 18 06:31 PM
Tingley WhittemoreChief Medical OfficerAug 16Sale3.815,56321,19576,437Aug 18 06:33 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerAug 16Sale3.814,45216,96264,542Aug 18 06:31 PM
Hoey TimothyChief Scientific OfficerAug 16Sale3.814,00715,267254,639Aug 18 06:34 PM
COLUMN GROUP III GP, LP10% OwnerMar 10Buy2.606,77917,59611,377,053Mar 14 04:12 PM
GOEDDEL DAVID VDirectorMar 10Buy2.606,77917,59611,377,053Mar 14 04:09 PM